PICALM
Phosphatidylinositol-binding clathrin assembly protein
Also known as: CALM, CLTH, PICAL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13492
- Gene
- PICALM
- Ensembl
- ENSG00000073921
- Chromosome
- 11
- Canonical length
- 652 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a clathrin assembly protein, which recruits clathrin and adaptor protein complex 2 (AP2) to cell membranes at sites of coated-pit formation and clathrin-vesicle assembly. The protein may be required to determine the amount of membrane to be recycled, possibly by regulating the size of the clathrin cage. The protein is involved in AP2-dependent clathrin-mediated endocytosis at the neuromuscular junction. A chromosomal translocation t(10;11)(p13;q14) leading to the fusion of this gene and the MLLT10 gene is found in acute lymphoblastic leukemia, acute myeloid leukemia and malignant lymphomas. The polymorphisms of this gene are associated with the risk of Alzheimer disease. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
652 residues, UniProt reviewed canonical sequence.
>Q13492|PICALM
1 MSGQSLTDRI TAAQHSVTGS AVSKTVCKAT THEIMGPKKK HLDYLIQCTN EMNVNIPQLA
61 DSLFERTTNS SWVVVFKSLI TTHHLMVYGN ERFIQYLASR NTLFNLSNFL DKSGLQGYDM
121 STFIRRYSRY LNEKAVSYRQ VAFDFTKVKR GADGVMRTMN TEKLLKTVPI IQNQMDALLD
181 FNVNSNELTN GVINAAFMLL FKDAIRLFAA YNEGIINLLE KYFDMKKNQC KEGLDIYKKF
241 LTRMTRISEF LKVAEQVGID RGDIPDLSQA PSSLLDALEQ HLASLEGKKI KDSTAASRAT
301 TLSNAVSSLA STGLSLTKVD EREKQAALEE EQARLKALKE QRLKELAKKP HTSLTTAASP
361 VSTSAGGIMT APAIDIFSTP SSSNSTSKLP NDLLDLQQPT FHPSVHPMST ASQVASTWGD
421 PFSATVDAVD DAIPSLNPFL TKSSGDVHLS ISSDVSTFTT RTPTHEMFVG FTPSPVAQPH
481 PSAGLNVDFE SVFGNKSTNV IVDSGGFDEL GGLLKPTVAS QNQNLPVAKL PPSKLVSDDL
541 DSSLANLVGN LGIGNGTTKN DVNWSQPGEK KLTGGSNWQP KVAPTTAWNA ATMAPPVMAY
601 PATTPTGMIG YGIPPQMGSV PVMTQPTLIY SQPVMRPPNP FGPVSGAQIQ FMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PICALM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 172 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 172 nTPM
- blood vessel: 166 nTPM
- kidney: 157 nTPM
- placenta: 148 nTPM
- liver: 137 nTPM
- urinary bladder: 130 nTPM
Single-cell type
- neutrophils: 4,207 nCPM
- microglia: 1,365 nCPM
- podocytes: 1,194 nCPM
- neutrophil progenitors: 932 nCPM
- renal collecting duct intercalated cells: 889 nCPM
- monocytes: 866 nCPM
Immune cell
- neutrophil: 41 nTPM
- classical monocyte: 14 nTPM
- non-classical monocyte: 13 nTPM
- intermediate monocyte: 12 nTPM
- myeloid DC: 11 nTPM
- memory CD8 T-cell: 8 nTPM
Brain region
- white matter: 446 nTPM
- basal ganglia: 385 nTPM
- medulla oblongata: 328 nTPM
- midbrain: 326 nTPM
- pons: 319 nTPM
- cerebellum: 304 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid-beta clearance by transcytosis
- axonogenesis
- clathrin coat assembly
- clathrin-dependent endocytosis
- dendrite morphogenesis
- endocytosis
- endosomal transport
- hemopoiesis
- intracellular iron ion homeostasis
- learning or memory
- membrane bending
- multicellular organismal-level iron ion homeostasis
- negative regulation of gene expression
- negative regulation of protein localization to cell surface
- negative regulation of protein localization to plasma membrane
- negative regulation of receptor-mediated endocytosis
- positive regulation of amyloid precursor protein catabolic process
- positive regulation of amyloid-beta formation
- positive regulation of DNA-templated transcription
- positive regulation of Ras protein signal transduction
- protein-containing complex assembly
- receptor internalization
- receptor-mediated endocytosis
- regulation of amyloid precursor protein catabolic process
- regulation of endocytosis
- regulation of protein localization
- regulation of vesicle size
- synaptic vesicle maturation
- vesicle budding from membrane
- vesicle cargo loading
- vesicle-mediated transport
Molecular functions
- 1-phosphatidylinositol binding
- amyloid-beta binding
- cadherin binding
- clathrin binding
- clathrin heavy chain binding
- low-density lipoprotein particle receptor binding
- phosphatidylinositol-4,5-bisphosphate binding
- small GTPase binding
- SNARE binding
- tau protein binding
Cellular components
- cell surface
- clathrin coat of coated pit
- clathrin-coated endocytic vesicle
- clathrin-coated pit
- clathrin-coated vesicle
- cytosol
- early endosome
- endosome to plasma membrane transport vesicle
- extrinsic component of presynaptic endocytic zone membrane
- Golgi apparatus
- membrane
- neurofibrillary tangle
- neuronal cell body
- nucleus
- perinuclear region of cytoplasm
- plasma membrane
- postsynaptic membrane
- presynaptic membrane
- synaptic vesicle
- vesicle
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PICALM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PICALM as an antibody target. Whether an autoantibody or antibody against PICALM could matter depends on whether native PICALM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PICALM is annotated at the cell surface, where native PICALM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PICALM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...